<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0010163'>Hemolysis</z:mp> may contribute to <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The authors examined blood carboxyhemoglobin corrected for inspired CO (COHbc) to index <z:chebi fb="4" ids="30413">heme</z:chebi> catabolism and serum conjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> fractions to reflect <z:chebi fb="0" ids="16990">bilirubin</z:chebi> conjugation </plain></SENT>
<SENT sid="2" pm="."><plain>Both parameters were related to <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronosyltransferase 1A1 (UGT) promoter polymorphism, associated with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, in term male newborns </plain></SENT>
<SENT sid="3" pm="."><plain>COHbc was expressed as percentage of total <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, and total conjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> (TCB) value as a percentage of serum total <z:chebi fb="0" ids="16990">bilirubin</z:chebi> (STB), (TCB/STB[%]) </plain></SENT>
<SENT sid="4" pm="."><plain>A production/conjugation index, COHbc/(TCB/STB[%]), represented <z:chebi fb="0" ids="16990">bilirubin</z:chebi> production divided by conjugation </plain></SENT>
<SENT sid="5" pm="."><plain>UGT promoter genotype was designated according to the number of promoter TA insertions in each allele: 6/6, homozygous <z:mpath ids='MPATH_458'>normal</z:mpath>; 6/7, heterozygous; 7/7, homozygous variant </plain></SENT>
<SENT sid="6" pm="."><plain>STB and COHbc values were higher in the 7/7 subgroup than the other counterparts (P &lt;.01) </plain></SENT>
<SENT sid="7" pm="."><plain>The COHbc/(TCB/STB[%]) was higher in the 7/7 than either the 6/6 or 6/7 subsets (1.93 [1.31-2.88] vs. 0.85 [0.51-1.72] and 0.84 [0.53-1.87], respectively; P &lt;.01) </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, 7/7 UGT promoter polymorphism was associated with increased blood COHbc values (unexpected finding) as well as diminished serum total conjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> ratios (expected finding) </plain></SENT>
<SENT sid="9" pm="."><plain>The <z:hpo ids='HP_0001878'>increased hemolysis</z:hpo> may contribute to the pathogenesis of increased STB values seen in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, and exacerbate <z:hpo ids='HP_0003265'>neonatal hyperbilirubinemia</z:hpo> associated with the promoter polymorphism </plain></SENT>
</text></document>